These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15757587)

  • 1. [Study of resistance using the TRUGENE HIV-1 genotyping system and analysis of agreement between rule-based algorithms and virtual phenotyping].
    Nogales MC; Serrano MC; Bernal S; Jarana R; Pérez de la Rosa L; Fernández-Palacín A; Almeida C; Martín-Mazuelos E
    Enferm Infecc Microbiol Clin; 2005 Mar; 23(3):149-55. PubMed ID: 15757587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rate of genotypic mutations and resistance to antiretroviral drugs in a general hospital].
    Fernández Lisón LC; Fernández Pereira LM; Romero Chala S
    Farm Hosp; 2011; 35(4):191-6. PubMed ID: 21087876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiology of genotypic resistance of HIV-1 in Valencia. A 4-year study].
    Molina JM; Córdoba J; Gil A; Gobernado M
    Rev Esp Quimioter; 2007 Sep; 20(3):346-53. PubMed ID: 18080033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiretroviral therapy-experienced patients receiving abacavir/efavirenz/amprenavir in the CNA2007 study.
    Ait-Khaled M; Rakik A; Griffin P; Stone C; Richards N; Thomas D; Falloon J; Tisdale M;
    Antivir Ther; 2003 Apr; 8(2):111-20. PubMed ID: 12741623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evolution of HIV resistance mutations in the Valme referral center].
    Nogales MC; Castro C; Martín-Mazuelos E
    Enferm Infecc Microbiol Clin; 2007 Feb; 25(2):159. PubMed ID: 17288915
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV-1 drug resistance and associated factors among adults failing first-line highly active antiretroviral therapy in Ho Chi Minh City, Vietnam.
    Pham QD; Huynh TK; Luong TT; Tran T; Vu TX; Truong LX
    HIV Clin Trials; 2013; 14(1):34-44. PubMed ID: 23372113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of genotypic resistance to nucleoside analogues, nonnucleoside analogues, and protease inhibitors in HIV-infected persons in Athens, Greece.
    Panos G; Charatsis G; Paparizos V; Kazantzi M; Falagas ME
    AIDS Res Hum Retroviruses; 2008 Jan; 24(1):43-51. PubMed ID: 18275347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.
    Muñoz M; Carmona R; Pérez-Alvarez L; Cilla G; Suarez MD; Delgado E; Contreras G; Corral J; de Goicoetxea MJ; Medrano L; Lezaún MJ; Nájera R;
    J Clin Virol; 2005 Jul; 33(3):224-9. PubMed ID: 15911444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
    Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic variation of HIV-1 reverse transcriptase and protease: comparative analysis of clade C and clade B.
    Grossman Z; Vardinon N; Chemtob D; Alkan ML; Bentwich Z; Burke M; Gottesman G; Istomin V; Levi I; Maayan S; Shahar E; Schapiro JM;
    AIDS; 2001 Aug; 15(12):1453-60. PubMed ID: 11504976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of antiretroviral mutants in HIV patients with treatment failures and the effect of risk factors in the virological failures.
    Taylor-Castillo L; Herrera-Martínez G; León-Bratti MP; Boza R; León-Rodríguez B; Luftig RB; Visoná K
    Rev Inst Med Trop Sao Paulo; 2005; 47(6):327-31. PubMed ID: 16553322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
    Little SJ; Daar ES; D'Aquila RT; Keiser PH; Connick E; Whitcomb JM; Hellmann NS; Petropoulos CJ; Sutton L; Pitt JA; Rosenberg ES; Koup RA; Walker BD; Richman DD
    JAMA; 1999 Sep 22-29; 282(12):1142-9. PubMed ID: 10501117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary drug resistance in antiretroviral-naïve injection drug users.
    Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
    Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
    de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy.
    Aleman S; Söderbärg K; Visco-Comandini U; Sitbon G; Sönnerborg A
    AIDS; 2002 May; 16(7):1039-44. PubMed ID: 11953470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.
    Salomon H; Wainberg MA; Brenner B; Quan Y; Rouleau D; Coté P; LeBlanc R; Lefebvre E; Spira B; Tsoukas C; Sekaly RP; Conway B; Mayers D; Routy JP
    AIDS; 2000 Jan; 14(2):F17-23. PubMed ID: 10708278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithms.
    Kijak GH; Rubio AE; Pampuro SE; Zala C; Cahn P; Galli R; Montaner JS; Salomón H
    HIV Med; 2003 Jan; 4(1):72-8. PubMed ID: 12534963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of two HIV-1 infectors during initial antiretroviral treatment, and the emergence of phenotypic resistance in reverse transcriptase-associated mutation patterns.
    Guo W; Han J; Zhuang D; Liu S; Liu Y; Li L; Li H; Bao Z; Wang F; Li J
    Virol J; 2015 Nov; 12():187. PubMed ID: 26578099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression.
    Václavíková J; Weber J; Machala L; Reinis M; Linka M; Brůcková M; Vandasová J; Stanková M; Konvalinka J
    Acta Virol; 2005; 49(1):29-36. PubMed ID: 15929396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral resistance and genetic diversity of human immunodeficiency virus type 1 isolates from the Federal District, Central Brazil.
    Cerqueira DM; Amorim RM; Silva RR; Camara GN; Brígido MM; Martins CR
    Mem Inst Oswaldo Cruz; 2004 Dec; 99(8):877-82. PubMed ID: 15761606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.